Study on the mechanism of Yangxin Xiaobi decoction in the treatment of stable angina pectoris based on network pharmacology
Objective To investigate the mechanism of Yangxin Xiaobi decoction in the treatment of stable angina pectoris by network pharmacology. Methods The main active components and its predicted targets of Yangxin Xiaobi decoction were screened in Traditional Chinese Medicine Systems Pharmacology (TCMSP). The related therapeutic targets of stable angina pectoris were obtained from DrugBank and Therapeutic Target Database (TTD). Subsequently,protein-protein interaction network were constructed by STRING database,and the network diagrams of active ingredient-therapeutic targets of stable angina pectoris target were drawn using Cytoscape software. Results A total of 126 targets of Yangxin Xiaobi decoction in the treatment of stable angina pectoris were screened,and 2305 interactions were obtained. According to their degree values,quercetin,kaempferol,luteolin,β-sitosterol and tanshinone ⅡA were the top 5 compounds in the network. The results of GO and KEGG analysis showed that Yangxin Xiaobi decoction might exert beneficial effects on stable angina pectoris by affecting the biological processes including movement of cell components,lipid localization,oxidative stress,DNA transcription,coagulation process,adenosine triphosphate metabolism,anti-regulation of immunity and inflammation,calcium ion transport,etc. Furthermore,the hypoxia inducible factor-1,Toll-like receptors,C-type lectin receptors,fluid shear and atherosclerosis,T helper cell 17/interleukin-17,T cell receptors,tumor necrosis factor,relaxin,advanced glycation end products and the signaling pathways of its receptor may get involved in the process. Conclusion The material basis and mechanism of Yangxin Xiaobi decoction in treating stable angina pectoris may be related to the the above-mentioned chemical components and related-biological processes and signaling pathways.
NETL
NSTL
万方数据
